Cartesian Therapeutics, Inc. (RNAC) stock
RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$6.08−0.27 (-4.25%)
Close on Nov 16, 2026Market cap $183.95MP/E –Yield –
Cartesian Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cartesian Therapeutics's enterprise value was $112.21M on Nov 10, 2026, against $51.38M a year earlier. Over the last 5 years it ranged from -$32.87M to $271.18M, with a median of $88.09M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $112.21M | +154.4% |
| 2025 | Dec 31, 2025 | $44.10M | -78.9% |
| 2024 | Dec 31, 2024 | $208.79M | +670.7% |
| 2023 | Dec 29, 2023 | $27.09M | +2.3% |
| 2022 | Dec 30, 2022 | $26.48M | -88.9% |
| 2021 | Dec 31, 2021 | $237.68M | +33.0% |
| 2020 | Dec 31, 2020 | $178.66M | +122.0% |
| 2019 | Dec 31, 2019 | $80.47M | +785.4% |
| 2018 | Dec 31, 2018 | $9.09M | -91.9% |
| 2017 | Dec 29, 2017 | $112.61M | -51.6% |
| 2016 | Dec 30, 2016 | $232.65M | – |
See a number that looks wrong?